Ethambutol(EMB) has been available to treat tuberculosis (TB) since the 1960s. The original formulation of EMB was a racemic mixture of its L and D forms. The D form of ethambutol was known for its therapeutic effect; however, the L form was known for its toxicity and hence, discontinued.Mycobacterium tuberculosis but not so much against viruses, fungi, or other bacteria. Antituberculosis medications used in conjunction with EMB include cycloserine, ethionamide, pyrazinamide, viomycin, isoniazid, aminosalicylic acid, and streptomycin.